IL22 and autoimmune polyendocrine syndrome type 1: An antibody panel can help orient toward an autoimmune etiology and therefore toward APECED syndrome at the early stage of the disease, even if the specificity and sensitivity of some antibodies were not as good as previously reported, with IL-22 seeming the most frequently identified in CMC.